Skip to main navigation Skip to search Skip to main content

Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression

Research output: Contribution to journal › Review Article › Research › peer-review

Abstract

Female gonadal hormones, particularly estrogen and progesterone, are not only central to reproductive health but also play a crucial role in regulating mood, cognition, and overall brain health. These hormones have a significant impact on the central nervous system, influencing key processes such as neurotransmission, neuroplasticity, and brain development. Increasing evidence shows that hormonal fluctuations contribute to the onset and progression of mental health disorders that disproportionately affect women, particularly premenstrual dysphoric disorder (PMDD), postnatal depression (PND), and menopausal depression. This paper explores the current evidence regarding the neurobiological effects of female hormones on the brain and discusses the therapeutic approaches in conditions such as PMDD, PND, and menopausal depression.

Original languageEnglish
Article number1528544
Number of pages14
JournalFrontiers in Pharmacology
Volume16
DOIs
Publication statusPublished - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • estrogen
  • gonadal hormones
  • menopausal depression
  • postnatal depression
  • premenstrual dysphoric disorder
  • progesterone
  • women's mental health

Cite this